Impacts of COVID-19 Pandemic on Listed Companies in Vietnam

Abstract

This study explores the impacts of COVID-19 pandemic on the performance of companies listed on the Ho Chi Minh City Stock Exchange (HoSE) and Hanoi Stock Exchange (HNX) over the period from the first quarter of 2019 to the fourth quarter of 2021. The study finds out that these following factors: (1) Cumulative number of COVID-19 cases (Cumulativecases), (2) Number of new Covid 19 cases (NewCases), (3) Business size (Firmsize), (4) Financial leverage (Leverage), (5) Tangibility of assets (Tangibility), and (6) Cashflow (Cashflow) all impact the performance of listed companies in Vietnam.
Keywords
business performance financial leverage asset tangibility cash flow Vietnam’s stock market impacts of the COVID-19.

References

1.
Bose, S., Shams, S., Ali, M. J., & Mihret, D. (2022). COVID-19 impact, sustainability performance and firm value: international evidence. Accounting & Finance, 62(1), 597-643.
2.
Fahlenbrach, R., Rageth, K., & Stulz, R. M. (2021). How valuable is financial flexibility when revenue stops? Evidence from the COVID-19 crisis. The Review of Financial Studies, 34(11), 5474-5521.
3.
Khatib, S. F., & Nour, A. N. I. (2021). The impact of corporate governance on firm performance during the COVID-19 pandemic: Evidence from Malaysia. Journal of Asian Finance, Economics and Business, 8(2), 943-952.
4.
Liu, H., Manzoor, A., Wang, C., Zhang, L., & Manzoor, Z. (2020). The COVID-19 outbreak and affected countries stock markets response. International Journal of Environmental Research and Public Health, 17(8), 2800.
5.
Liu, H., Yi, X., & Yin, L. (2021). The impact of operating flexibility on firms performance during the COVID-19 outbreak: Evidence from China. Finance Research Letters, 38, 101808.
6.
Myers, S. C., & Majluf, N. S. (1984). Corporate financing and investment decisions when firms have information that investors do not have. Journal of Financial Economics, 13(2), 187-221.
7.
Papachristou, S., Stamatiou, I., Stoian, A. P., & Papanas, N. (2021). New-onset diabetes in COVID-19: time to frame its fearful symmetry. Diabetes Therapy, 12, 461-464.